[ad_1]
Pfizer has provided data to the United States Food and Drug Administration (FDA) indicating that the vaccine is stable when stored between -15 and -25 Celsius, temperatures common in pharmaceutical freezers and refrigerators..
The company is asking the Food and Drug Administration to update its vaccine license, to allow the vials to be stored at these temperatures for two weeks, as an alternative or supplement to cold freezers..
And “Pfizer” previously announced that the vaccine should be stored at temperatures between -60 and -80 Celsius, and that it can be stored at these temperatures for a period of 6 months.
These requirements, which have posed challenges for rural hospitals, pharmacies and other vaccination sites, will become an additional option if the FDA approves the changes..
Pfizer CEO Albert Burla said the company was continually conducting studies “to support the production of the vaccine on a commercial scale, with the aim of making it as available as possible to healthcare providers and individuals with disabilities. United States and around the world.“.
Burla added that if the new storage option is approved, “it will give pharmacies and vaccination centers more flexibility in managing their vaccine supplies.”
[ad_2]
Source link
